PAVmed Inc (PAVMZ)
USD 0.02
(32.0%)
USD 0.02
(32.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -75.74 Million USD | 29.03% |
| 2022 | -99.41 Million USD | -71.33% |
| 2021 | -55.9 Million USD | -125.81% |
| 2020 | -35.81 Million USD | -55.87% |
| 2019 | -16.67 Million USD | -27.49% |
| 2018 | -12.07 Million USD | -8.25% |
| 2017 | -11.15 Million USD | -97.47% |
| 2016 | -5.64 Million USD | -217.86% |
| 2015 | -1.77 Million USD | -1304.67% |
| 2014 | -126.47 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -13.37 Million USD | 18.49% |
| 2024 Q1 | -13.45 Million USD | -7.48% |
| 2023 Q3 | -15.52 Million USD | 2.43% |
| 2023 FY | - USD | 29.03% |
| 2023 Q1 | -21.77 Million USD | 8.41% |
| 2023 Q4 | -15.65 Million USD | -0.84% |
| 2023 Q2 | -15.91 Million USD | 26.93% |
| 2022 Q1 | -19.24 Million USD | 1.38% |
| 2022 Q4 | -23.77 Million USD | 0.28% |
| 2022 Q3 | -23.84 Million USD | 14.11% |
| 2022 FY | - USD | -71.33% |
| 2022 Q2 | -27.76 Million USD | -44.27% |
| 2021 Q2 | -12.95 Million USD | -102.95% |
| 2021 Q4 | -19.51 Million USD | -43.1% |
| 2021 FY | - USD | -125.81% |
| 2021 Q1 | -6.38 Million USD | -214.59% |
| 2021 Q3 | -13.63 Million USD | -5.26% |
| 2020 Q1 | -13.66 Million USD | -155.34% |
| 2020 FY | - USD | -55.87% |
| 2020 Q4 | -2.02 Million USD | 61.0% |
| 2020 Q2 | -3.08 Million USD | 77.41% |
| 2020 Q3 | -5.2 Million USD | -68.49% |
| 2019 Q2 | -3.47 Million USD | 6.01% |
| 2019 FY | - USD | -27.49% |
| 2019 Q4 | -5.35 Million USD | -87.12% |
| 2019 Q3 | -2.86 Million USD | 17.73% |
| 2019 Q1 | -3.69 Million USD | 23.35% |
| 2018 Q3 | -2.56 Million USD | 6.24% |
| 2018 Q2 | -2.73 Million USD | -40.94% |
| 2018 Q1 | -1.94 Million USD | -2.93% |
| 2018 FY | - USD | -8.25% |
| 2018 Q4 | -4.82 Million USD | -88.07% |
| 2017 Q4 | -1.88 Million USD | 4.05% |
| 2017 Q3 | -1.96 Million USD | 35.56% |
| 2017 Q1 | -3.16 Million USD | -85.19% |
| 2017 Q2 | -3.05 Million USD | 3.59% |
| 2017 FY | - USD | -97.47% |
| 2016 Q2 | -1.31 Million USD | -88.59% |
| 2016 FY | - USD | -217.86% |
| 2016 Q3 | -1.92 Million USD | -46.67% |
| 2016 Q4 | -1.7 Million USD | 11.32% |
| 2016 Q1 | -696.74 Thousand USD | 4.65% |
| 2015 Q2 | -360.6 Thousand USD | -146.42% |
| 2015 Q3 | -538.9 Thousand USD | -49.44% |
| 2015 Q4 | -730.75 Thousand USD | -35.6% |
| 2015 Q1 | -146.33 Thousand USD | 0.0% |
| 2015 FY | - USD | -1304.67% |
| 2014 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Acutus Medical, Inc. | -13.48 Million USD | -461.593% |
| Axonics, Inc. | 7.77 Million USD | 1074.174% |
| INVO Bioscience, Inc. | -6.88 Million USD | -1000.897% |
| CVRx, Inc. | -38.73 Million USD | -95.559% |
| iRhythm Technologies, Inc. | -96.86 Million USD | 21.804% |
| Monogram Orthopaedics, Inc. | -16.85 Million USD | -349.356% |
| MaxCyte, Inc. | -44.12 Million USD | -71.642% |
| ClearPoint Neuro, Inc. | -20.98 Million USD | -260.865% |
| PROCEPT BioRobotics Corporation | -98.09 Million USD | 22.787% |
| Sintx Technologies, Inc. | -6.6 Million USD | -1047.606% |
| Accelerate Diagnostics, Inc. | -49.77 Million USD | -52.181% |
| Apyx Medical Corporation | -18.11 Million USD | -318.187% |
| Cutera, Inc. | -136.56 Million USD | 44.536% |
| Helius Medical Technologies, Inc. | -12.1 Million USD | -525.605% |
| NeuroPace, Inc. | -22.83 Million USD | -231.707% |
| IRIDEX Corporation | -7.44 Million USD | -916.944% |
| Tactile Systems Technology, Inc. | 24.54 Million USD | 408.635% |
| enVVeno Medical Corporation | -25.01 Million USD | -202.75% |
| TELA Bio, Inc. | -40.63 Million USD | -86.405% |
| Tandem Diabetes Care, Inc. | -194.65 Million USD | 61.09% |
| UFP Technologies, Inc. | 72.74 Million USD | 204.123% |
| Modular Medical, Inc. | -17.1 Million USD | -342.858% |
| STRATA Skin Sciences, Inc. | -3.38 Million USD | -2140.888% |
| LENSAR, Inc. | -8.71 Million USD | -769.199% |
| Integra LifeSciences Holdings Corporation | 383.56 Million USD | 119.747% |
| Surmodics, Inc. | 1.18 Million USD | 6475.589% |
| Vivos Therapeutics, Inc. | -16.67 Million USD | -354.225% |
| Inogen, Inc. | -45.67 Million USD | -65.814% |
| Tivic Health Systems, Inc. | -8.06 Million USD | -839.494% |
| RxSight, Inc. | -41.03 Million USD | -84.57% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1230.665% |
| Lucid Diagnostics Inc. | -49.75 Million USD | -52.242% |
| Nano-X Imaging Ltd. | -47.69 Million USD | -58.812% |
| Nexalin Technology, Inc. | -5.69 Million USD | -1230.665% |
| PetVivo Holdings, Inc. | -10.49 Million USD | -621.731% |
| Cytek Biosciences, Inc. | -4.4 Million USD | -1618.285% |
| Alphatec Holdings, Inc. | -110.59 Million USD | 31.512% |
| Rapid Micro Biosystems, Inc. | -53.75 Million USD | -40.894% |
| Dynatronics Corporation | -976 Thousand USD | -7660.387% |
| TriSalus Life Sciences, Inc. | -58.29 Million USD | -29.922% |
| InMode Ltd. | 196.28 Million USD | 138.588% |
| Bruker Corporation | 599 Million USD | 112.645% |
| Movano Inc. | -29.12 Million USD | -160.058% |
| Orthofix Medical Inc. | -86.98 Million USD | 12.925% |
| FONAR Corporation | 28.25 Million USD | 368.098% |
| BioSig Technologies, Inc. | -28.15 Million USD | -169.056% |
| Envoy Medical, Inc. | -18.23 Million USD | -315.298% |
| Align Technology, Inc. | 799.03 Million USD | 109.479% |
| Anika Therapeutics, Inc. | 2.51 Million USD | 3110.413% |
| Talis Biomedical Corporation | -66.04 Million USD | -14.682% |
| Cerus Corporation | -26.53 Million USD | -185.431% |
| 908 Devices Inc. | -34.02 Million USD | -122.607% |
| Nemaura Medical Inc. | -7.28 Million USD | -939.405% |
| Outset Medical, Inc. | -153.78 Million USD | 50.749% |
| NanoVibronix, Inc. | -3.43 Million USD | -2105.007% |
| Venus Concept Inc. | -26.11 Million USD | -190.055% |
| Telesis Bio, Inc. | -40.49 Million USD | -87.05% |
| Treace Medical Concepts, Inc. | -39 Million USD | -94.17% |
| Quipt Home Medical Corp. | 44.07 Million USD | 271.864% |
| IRadimed Corporation | 20.8 Million USD | 464.133% |
| Tenon Medical, Inc. | -15.52 Million USD | -387.777% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -596.799% |
| Pulmonx Corporation | -55.09 Million USD | -37.483% |
| iCAD, Inc. | -6.56 Million USD | -1053.724% |
| QT Imaging Holdings, Inc. | -3.38 Million USD | -2137.058% |
| NeuroOne Medical Technologies Corporation | -11.75 Million USD | -544.285% |
| Viemed Healthcare, Inc. | 36.67 Million USD | 306.511% |
| SI-BONE, Inc. | -34.44 Million USD | -119.886% |
| Semler Scientific, Inc. | 23.58 Million USD | 421.09% |
| Biotricity, Inc. | -8.82 Million USD | -757.948% |
| Cytosorbents Corporation | -28.81 Million USD | -162.894% |
| DexCom, Inc. | 916.7 Million USD | 108.262% |
| ZimVie Inc. | 91.07 Million USD | 183.166% |
| Aethlon Medical, Inc. | -11.84 Million USD | -539.221% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | -2046.882% |
| IceCure Medical Ltd | -15.25 Million USD | -396.571% |
| Sight Sciences, Inc. | -49.41 Million USD | -53.277% |
| Insulet Corporation | 323.6 Million USD | 123.406% |
| Profound Medical Corp. | -27.12 Million USD | -179.249% |
| electroCore, Inc. | -17.76 Million USD | -326.475% |
| Bioventus Inc. | -23.07 Million USD | -228.314% |
| InspireMD, Inc. | -20.91 Million USD | -262.211% |
| PAVmed Inc. | -75.74 Million USD | -0.0% |
| Nuwellis, Inc. | -16.35 Million USD | -363.084% |
| OrthoPediatrics Corp. | -8.38 Million USD | -803.735% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | -2046.882% |
| BrainsWay Ltd. | -2.31 Million USD | -3177.456% |
| BIOLASE, Inc. | -15.13 Million USD | -400.31% |
| Beyond Air, Inc. | -59.03 Million USD | -28.309% |
| AxoGen, Inc. | -13.32 Million USD | -468.292% |
| Inari Medical, Inc. | 7.11 Million USD | 1164.839% |
| Heart Test Laboratories, Inc. | -6.15 Million USD | -1130.378% |
| Autonomix Medical, Inc. Common Stock | -15.26 Million USD | -396.148% |
| AdaptHealth Corp. | -171.09 Million USD | 55.73% |
| Quanterix Corporation | -38.08 Million USD | -98.861% |
| Viveve Medical, Inc. | -20.61 Million USD | -267.376% |
| LivaNova PLC | 39.01 Million USD | 294.131% |
| Co-Diagnostics, Inc. | -41.47 Million USD | -82.618% |
| Varex Imaging Corporation | 67.2 Million USD | 212.711% |
| Vivani Medical, Inc. | -26.6 Million USD | -184.659% |
| ReShape Lifesciences Inc. | -14.48 Million USD | -422.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | -10.87 Million USD | -596.799% |
| Sensus Healthcare, Inc. | 30 Thousand USD | 252573.333% |
| Pacific Biosciences of California, Inc. | -277.28 Million USD | 72.684% |
| TransMedics Group, Inc. | -7.6 Million USD | -896.212% |
| ReWalk Robotics Ltd. | -21.76 Million USD | -247.999% |
| NeuroMetrix, Inc. | -7.09 Million USD | -967.419% |
| Spectral AI, Inc. | -12.26 Million USD | -517.697% |
| Hyperfine, Inc. | -47.06 Million USD | -60.944% |
| Establishment Labs Holdings Inc. | -58.3 Million USD | -29.902% |
| Biomerica, Inc. | -5.99 Million USD | -1163.841% |
| Bone Biologics Corporation | 479.57 Thousand USD | 15893.666% |
| AVITA Medical, Inc. | -39.56 Million USD | -91.424% |
| Bluejay Diagnostics, Inc. | -9.17 Million USD | -725.712% |
| Silk Road Medical, Inc | -45.08 Million USD | -68.017% |